This HTML5 document contains 229 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1136/
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12https://makg.org/entity/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42121483
rdf:type
wikibase:Item
schema:description
2017年论文 2017 nî lūn-bûn научни чланак articolo scientifico სამეცნიერო სტატია artículu científicu espublizáu en 2017 tieteellinen artikkeli scienca artikolo 2017年论文 vědecký článek 2017年论文 2017年論文 tudományos cikk artigo científico ২৬ সেপ্টেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ επιστημονικό άρθρο vedecký článok научни чланак наукова стаття, опублікована у вересні 2017 naučni članak מאמר מדעי 2017年論文 wetenschappelijk artikel article scientifique artículo científico publicado en 2017 artikull shkencor articol științific scientific article published on 26 September 2017 artigo científico 2017年论文 videnskabelig artikel 2017年论文 научная статья bilimsel makale บทความทางวิทยาศาสตร์ article científic teaduslik artikkel 2017年の論文 2017年论文 vetenskaplig artikel article scientific 2017年論文 2017년 논문 2017年論文 vitenskapelig artikkel artykuł naukowy artikel ilmiah scientific article published on 26 September 2017 bài báo khoa học artigo científico wissenschaftlicher Artikel мақолаи илмӣ 2017年論文 научна статия vitskapeleg artikkel artikulong pang-agham scientific article published on 26 September 2017 مقالة علمية نشرت في 26 سبتمبر 2017
p:P577
wds:Q42121483-B54FEFE8-85F4-42D3-829E-486749A8BDBE
wdt:P577
2017-09-26T00:00:00Z
p:P407
wds:Q42121483-307FF249-04CD-41D8-85CE-3C18A2854025
wdt:P407
wd:Q1860
p:P2860
wds:Q42121483-E18634C1-01E6-4C6A-9278-5257A75D3798 wds:Q42121483-E566EA25-BDCB-4986-AD16-87EDA08434AB wds:Q42121483-F059DE0F-A71D-4D85-917F-2A3FA245A0D6 wds:Q42121483-F2986329-BA2E-4620-B4D5-9515FC5CFBA6 wds:Q42121483-CA2E7B7F-1016-43B4-A3B9-4E5EFA537382 wds:Q42121483-CD267AD0-BA6A-4133-B9CC-9FDED4088941 wds:Q42121483-C2DC6809-2F6E-4443-8C06-C2E2EF90971C wds:Q42121483-C65A960F-7270-4135-B69D-79F0266D9942 wds:Q42121483-C992D566-58BD-4898-81C6-F94E8E24295E wds:Q42121483-B9410763-C60D-4CD1-9156-3E8B2967DDBC wds:Q42121483-BC83091C-9AD2-45D2-B100-F99DFFC78B52 wds:Q42121483-B3A46427-20EF-469E-AD78-A433B4153FB1 wds:Q42121483-B895372B-4509-4ACA-8989-67E93E2DEB8D wds:Q42121483-B334407F-F957-4897-93D8-C02B4AFE9D19 wds:Q42121483-B338C2C2-3B78-491E-9919-844FD3328A06 wds:Q42121483-98BEAF26-D22C-4BE4-B789-CDA6FAF485C7 wds:Q42121483-9FC235FB-35CA-4EEB-B0E7-6D70F1B6525E wds:Q42121483-906B8BCE-D135-4FA9-B546-8FD729998858 wds:Q42121483-92709BD5-5822-409E-9EBA-B1277A314370 wds:Q42121483-9280D271-FCC5-47B9-BBEF-ACF42EF0A936 wds:Q42121483-98AFD38F-41D1-40FF-A567-179D45A27829 wds:Q42121483-8A169358-FE8B-4D6B-88A7-2037E27278F1 wds:Q42121483-8D4E4D1E-AFF8-4AFC-8685-6700B00941C3 wds:Q42121483-73DB7C22-7ED6-4E80-B908-4310F0ECAFE0 wds:Q42121483-782624A5-AA60-426D-8222-C5851F30A864 wds:Q42121483-7D26F2E3-8E16-475B-B996-8A986A896B13 wds:Q42121483-6053F971-CEEE-4CAD-9D86-234EA0AC30EC wds:Q42121483-53A8CE25-2472-4C86-92C2-4E2008BA94AA wds:Q42121483-5C9D1E8C-074C-4A12-A705-E1044855A292 wds:Q42121483-5F50DF09-4F78-431C-B54C-0C35A1945F0C wds:Q42121483-4ABE5FEA-9AE9-4A57-BF51-AA90C7A8F70B wds:Q42121483-4E7432C0-4AED-4C33-82C6-DB8B66D534FF wds:Q42121483-520D4BBD-B0EB-4D5A-A377-0DEB0A54B539 wds:Q42121483-41C4AC47-EFAB-4452-B045-FCFBA3A2F54F wds:Q42121483-43FCBA35-94D3-4F77-91A6-4A5F3FB7CA08 wds:Q42121483-45E98148-BBEB-45EA-9131-CF4E1A324A58 wds:Q42121483-4857E9ED-F3E7-4D85-B26F-23BACB796374 wds:Q42121483-3CF692D3-A17B-4F1C-B4CB-892A755E128D wds:Q42121483-3E1FC714-DF40-48DD-9B4E-6854C77DAEBF wds:Q42121483-401E140B-343C-4930-8A45-77DDE6D0C734 wds:Q42121483-4064E5BE-C2E4-4FB6-9046-2B08DCBC0FD0 wds:Q42121483-39585616-9656-4A2E-93EE-ACC4CCE8BB99 wds:Q42121483-39D0A0E5-9050-42D6-87BC-3B758AE88238 wds:Q42121483-3BD92BAB-B176-4EF4-940A-A32F26205EFF wds:Q42121483-2F6DBA17-E9D3-4300-86CF-983534E5BC05 wds:Q42121483-2F89CFB8-29E0-4CAE-B185-FAFB2A2D75FC wds:Q42121483-347989FB-677A-4DAF-A1AD-6F26A3CBFD51 wds:Q42121483-1F80AB86-EDD8-4DC8-A06F-944B64B89470 wds:Q42121483-14EC6483-FE66-40F3-AD21-B5C59117AB08 wds:Q42121483-1EAD7CB9-41DD-4B99-9F7C-9AC3FB45A001 wds:Q42121483-069083E9-F8C4-4DFB-8A38-3984221EDAE3
wdt:P2860
wd:Q30688001 wd:Q33256077 wd:Q81377140 wd:Q51109662 wd:Q77430935 wd:Q27860872 wd:Q34550160 wd:Q70606503 wd:Q68109843 wd:Q29616063 wd:Q33222832 wd:Q37710906 wd:Q87630446 wd:Q36374666 wd:Q42677290 wd:Q70791756 wd:Q82132610 wd:Q34081946 wd:Q83239864 wd:Q35554643 wd:Q33226724 wd:Q47657546 wd:Q44321551 wd:Q26859134 wd:Q34200704 wd:Q72471642 wd:Q33976382 wd:Q47317958 wd:Q34462557 wd:Q83172291 wd:Q34651182 wd:Q34547981 wd:Q34027517 wd:Q42661052 wd:Q46048883 wd:Q51168054 wd:Q33544536 wd:Q70642560 wd:Q57169361 wd:Q59546303 wd:Q26828418 wd:Q34651201 wd:Q37744356 wd:Q73065125 wd:Q82690898 wd:Q34315745 wd:Q37691184 wd:Q35552900 wd:Q37890664 wd:Q36550842 wd:Q33291408
p:P2093
wds:Q42121483-188B8AD5-A7AD-477B-A4F0-587B8FE66C95 wds:Q42121483-6348127F-B421-4419-8A5C-26071E30BF8B wds:Q42121483-ADA1AF9D-CB11-4F0F-9FD5-7D8B29766755 wds:Q42121483-8497CFDF-D225-48CC-A923-D6BBEF0D5E36 wds:Q42121483-D122BB69-C8A0-4DBE-B897-B7D18437E13C wds:Q42121483-E141E2BB-8906-4A7A-AC15-C2CB90210384
wdt:P2093
Ferdinand C Breedveld Kun Chen Stefan Florentinus Iain Sainsbury Hartmut Kupper Edward C Keystone
rdfs:label
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
skos:prefLabel
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
schema:name
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
p:P50
wds:Q42121483-20D80CEB-5C34-47B8-B78F-4621E4669741 wds:Q42121483-AD4DD107-8133-4EEB-BBDE-F89E28A1DA54 wds:Q42121483-B9693528-FB5B-4B0C-9EB2-C81A051CF7F4 wds:Q42121483-C6016498-ABD7-4E4C-A57B-60D9BAFFFA70 wds:Q42121483-6219B260-3DFB-4186-8064-A9C2B34253AD
wdt:P50
wd:Q66753681 wd:Q47262835 wd:Q93106996 wd:Q47265013 wd:Q19859634
p:P1476
wds:Q42121483-AD4DA3D3-51AC-47C7-AE29-52EE2B2F5CAE
wdt:P1476
Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone
p:P304
wds:Q42121483-F3B7B715-B795-4061-A259-7A850846FCBC
wdt:P304
e000445
p:P31
wds:Q42121483-A3FDA766-54E3-4434-AAC7-9BB2A50C1F6C
wdt:P31
wd:Q13442814
p:P921
wds:Q42121483-34D75D91-6ACF-48CE-BA67-8845F4B134D2 wds:Q42121483-BCE71176-E49E-4AE4-A552-56F00591E9B1 wds:Q42121483-1EE03CBE-FEDE-4C7E-A70D-53915322D807
wdt:P921
wd:Q422232 wd:Q348260 wd:Q187255
p:P698
wds:Q42121483-2ADA07AE-74AC-4DE0-9E48-50B35FFAC269
wdtn:P698
n8:29018564
wdt:P698
29018564
p:P1433
wds:Q42121483-4FBAFEDB-CAE2-45AA-A995-08906743CE48
wdt:P1433
wd:Q27726913
p:P433
wds:Q42121483-5FF12882-6478-4F3E-B8A9-787C2A785C1B
p:P478
wds:Q42121483-5E7EBE13-7415-4F9C-9990-E9376A4CDD38
wdt:P433
2
wdt:P478
3
p:P356
wds:Q42121483-B7EDBCD5-6B89-4AA7-8D15-FDF5E12C81E3
wdtn:P356
n11:RMDOPEN-2017-000445
wdt:P356
10.1136/RMDOPEN-2017-000445
p:P6366
wds:Q42121483-F5C7A9C7-8B60-4F79-B09F-6731AC575A14
wdtn:P6366
n12:2760739255
wdt:P6366
2760739255
p:P6179
wds:Q42121483-0F6F75B2-7CCA-4EE8-8C88-D5EB0F09716A
wdt:P6179
1091974028
p:P932
wds:Q42121483-89AF96FB-6DED-4AA7-9AD4-544B8CDC4BAA
wdt:P932
5623327
p:P1154
wds:Q42121483-7F44F5EA-1219-4621-82B7-9A62C549AFF8
wdt:P1154
2-s2.0-85030330093